Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.5800
+0.0200 (1.28%)
NASDAQ · Last Trade: Feb 6th, 2:38 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors